Clinic
Advanced Physicians P C
Advanced Physicians P C was paid $2.78M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoADVANCED PHYSICIANS P C
FOREST HILLS, NY 11375
FOREST HILLS, NY 11375
33aNPI1346563582assigned 03/02/2010
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$2.78M
24GClaims107,137
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in New York
Rank by total paid#32 of 118
Median peer was paid$372K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,468 | $197K | |
| 2019 | 4,390 | $137K | |
| 2020 | 8,512 | $257K | |
| 2021 | 15,022 | $464K | |
| 2022 | 21,296 | $587K | |
| 2023 | 30,635 | $621K | |
| 2024incomplete | 21,814 | $515K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 13,533 | 11,473 | $825K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.2% | 2,587 | 2,583 | $229K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 1,966 | 1,818 | $184K |
| 76770 | 5.9% | 2,239 | 2,233 | $164K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.6% | 3,869 | 3,441 | $155K |
| 76830 | Ultrasound, transvaginal | 4.8% | 1,823 | 1,796 | $134K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4.2% | 1,880 | 1,872 | $116K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 672 | 671 | $92K |
| 99385 | 3.2% | 866 | 864 | $90K | |
| 51741 | 3.0% | 5,676 | 5,098 | $84K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.2% | 670 | 668 | $61K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 2.0% | 2,505 | 2,494 | $56K |
90 more codes
| 76872 | 1.7% | 562 | $47K | |
| 51798 | 1.4% | 3,942 | $38K | |
| 51728 | 1.2% | 206 | $32K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 2,665 | $24K |
| 51784 | <1% | 573 | $22K | |
| 93975 | <1% | 181 | $21K | |
| 84403 | <1% | 1,348 | $21K | |
| 81002 | <1% | 12,740 | $20K | |
| 84402 | <1% | 1,229 | $19K | |
| 82670 | <1% | 1,030 | $19K | |
| 76857 | <1% | 363 | $19K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 866 | $16K |
| 81025 | <1% | 5,697 | $15K | |
| 64566 | <1% | 188 | $14K | |
| 99459 | <1% | 805 | $13K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,027 | $12K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 130 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 744 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 746 | $11K |
| 94762 | <1% | 1,986 | $10K | |
| 84144 | <1% | 648 | $9K | |
| 84154 | <1% | 767 | $8K | |
| 84153 | <1% | 782 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 253 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 432 | $7K |
| 83002 | <1% | 539 | $7K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 403 | $6K |
| 83001 | <1% | 530 | $6K | |
| 84146 | <1% | 479 | $6K | |
| 99386 | <1% | 53 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,044 | $5K |
| 87480 | <1% | 533 | $5K | |
| 82728 | <1% | 635 | $5K | |
| 82677 | <1% | 401 | $5K | |
| 88112 | <1% | 235 | $5K | |
| 96127 | <1% | 1,307 | $5K | |
| 82607 | <1% | 605 | $5K | |
| 82627 | <1% | 313 | $5K | |
| 84702 | <1% | 539 | $5K | |
| 82746 | <1% | 561 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 645 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,821 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 524 | $4K |
| 84439 | <1% | 600 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 32 | $4K |
| 86703 | <1% | 340 | $3K | |
| 86780 | <1% | 367 | $3K | |
| 88342 | <1% | 155 | $3K | |
| 86803 | <1% | 385 | $3K | |
| 76870 | <1% | 42 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 87 | $3K |
| 87510 | <1% | 272 | $3K | |
| 83550 | <1% | 637 | $2K | |
| 86696 | <1% | 201 | $2K | |
| 83525 | <1% | 264 | $2K | |
| 83540 | <1% | 635 | $2K | |
| 86706 | <1% | 321 | $2K | |
| 87110 | <1% | 253 | $2K | |
| 81000 | <1% | 610 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 45 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 24 | $1K |
| 87340 | <1% | 166 | $1K | |
| 88313 | <1% | 155 | $1K | |
| 80061 | Lipid panel | <1% | 212 | $983.24 |
| 87660 | <1% | 264 | $959.96 | |
| 81003 | <1% | 614 | $885.14 | |
| 76377 | <1% | 370 | $845.73 | |
| 82465 | <1% | 252 | $794.27 | |
| 80051 | <1% | 1,417 | $740.07 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $591.60 |
| 81514 | <1% | 45 | $452.71 | |
| 82533 | <1% | 29 | $360.36 | |
| 87481 | <1% | 113 | $326.79 | |
| 99402 | <1% | 12 | $279.14 | |
| 87640 | <1% | 16 | $261.87 | |
| 87529 | <1% | 16 | $258.54 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $229.39 |
| 84270 | <1% | 78 | $222.08 | |
| 86769 | <1% | 12 | $215.78 | |
| 87511 | <1% | 16 | $211.17 | |
| 87653 | <1% | 16 | $197.52 | |
| 86695 | <1% | 211 | $143.77 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 47 | $105.80 |
| 99406 | <1% | 12 | $100.69 | |
| 87106 | <1% | 12 | $83.59 | |
| 80050 | General health panel | <1% | 14 | $78.00 |
| 86704 | <1% | 12 | $55.97 | |
| 99000 | 0% | 16 | $0.00 | |
| 84436 | 0% | 52 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 295 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHUSTERMAN, DAVID (TREASURER)